Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

“Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us ...

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $115 per share, driven by new product pipelines and FDA clearances. Alcon's Unity VCS/CS systems received FDA clearance, set ...

Alcon ALC unveiled results from time and motion studies demonstrating superior efficiency with the UNITY Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery compared to the ...